Venous Thromboembolism clinical trials

Explore recruiting venous thromboembolism clinical trials.

Recruiting venous thromboembolism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Venous Thromboembolism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Master Protocol for a Phase 2 Randomized, Double-blind, Placebo-controlled Study of REGN9933 and REGN7508, Monoclonal Antibodies against Factor XI for Prevention of Venous Thromboembolism in Patients with a Peripherally Inserted Central Catheter (ROXI-CATH).

Spain, Romania, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

I4V-MC-JAJA (RA-BRIDGE): A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis

Hungary, Slovakia, Lithuania, Austria, France, Greece +9 more

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, Randomized, Open-Label, Blinded Endpoint Evaluation, Active-Controlled Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing Elective Primary Unilateral Total Knee Arthroplasty.

Latvia, Bulgaria, Hungary, Czechia, Poland, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

Cluster randomised trial of low molecular weight heparins - Directly through Epic

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

COmparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism

Ireland

Therapeutic use (Phase IV) EU CTIS Study details

Venous Thromboembolism trials by city

Venous Thromboembolism in Toronto Venous Thromboembolism in Vancouver Venous Thromboembolism in Montreal Venous Thromboembolism in Calgary Venous Thromboembolism in Edmonton Venous Thromboembolism in Ottawa Venous Thromboembolism in Winnipeg Venous Thromboembolism in Quebec City Venous Thromboembolism in Hamilton Venous Thromboembolism in Kitchener Venous Thromboembolism in London Venous Thromboembolism in Halifax Venous Thromboembolism in New York Venous Thromboembolism in Los Angeles Venous Thromboembolism in Chicago Venous Thromboembolism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease